CR
Crinetics Pharma
CRNX·NASDAQSan Diego CAFounded 2008250 employees
Mid CapbiotechPublicEndocrinologyRare Disease
Platform: Acromegaly SST
Market Cap
$3B
All Drugs
3
Clinical Trials
7
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (CRNX)
Loading CRNX stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Nidasertib | CRN-8326 | Approved | 4 | CD38 | OCDUrothelial Ca | ||
| CRN-1592 | CRN-1592 | Phase 1/2 | 2 | CD20 | EpilepsyAngelman | ||
| Cevirasimod | CRN-220 | Preclinical | 1 | CD19 | Thymoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)